Takeda

News
Takeda CEO confident about Shire merger

Takeda CEO confident about Shire merger

Takeda’s CEO has said he is confident that its $62 billion acquisition of Shire will go ahead, despite a rebellion from a dissident group of shareholders.

News
Bruce T. Martin Photography 508-655-7557 btm@brucetmartin.com 154 East Central St Natick MA 01760

FDA advisers back Shire constipation drug

Shire’s constipation drug prucalopride is moving closer to market – advisers to the FDA have just unanimously backed it as a treatment for chronic idiopathic constipation (CIC) in adults.